Board Of Regents Of The University Of Nebraska

Board Of Regents Of The University Of Nebraska, through its University of Nebraska Medical Center (UNMC) division in Omaha, Nebraska, operates as a prime recipient and contractor delivering specialized medical education, clinical training, biomedical research, and laboratory diagnostic services to federal health and defense agencies. UNMC is a non-profit, state-controlled academic medical institution under the parent Board of Regents of the University of Nebraska, operating as a 1862 land-grant university.

UNMC's federal footprint centers on research and graduate medical education. The institution holds a single-award indefinite delivery contract with the U.S. Army Training and Doctrine Command (TRADOC) valued at approximately $3.1 million through September 2026 to provide university affiliation services for the Interservice Physician Assistant Program (IPAP), including curriculum coordination, faculty appointments, student records management, and degree conferral. Recent delivery orders under this vehicle total $544,040 for physician assistant training cohorts, with performance in Omaha, Nebraska and San Antonio, Texas. UNMC also delivers purchase order work for the Air Force Research Laboratory on biocontainment care training and infectious disease air transport course development—a $3.0 million Phase I effort on the 711 HPW USAFSAM/ET Infectious Disease Air Transport Course—and provides DNA laboratory testing services to the Drug Enforcement Administration.

UNMC's primary customer concentration lies with the National Institutes of Health (NIH), which funds the majority of the institution's research awards. The top five agencies by award count—NIH parent agency, NIH National Cancer Institute, NIH National Institute of Allergy and Infectious Diseases (NIAID), NIH National Heart Lung and Blood Institute, and Health Resources and Services Administration—account for 37 percent of recent awards. By dollar value, NIAID dominates at $108.5 million across 101 awards, followed by Army Training and Doctrine Command at $13.8 million across 41 awards, and the Defense Health Agency at $4.6 million across 57 awards. The institution served 130 distinct federal customer agencies across its award portfolio.

UNMC's recent federal grant recipients hip spans infectious disease research, cancer biology, aging and neurodegenerative disease, medical education and workforce development, and public health preparedness. Representative federal grants include a $799,619 NIAID award for research on cylindrical protease modulation to eliminate Chlamydia trachomatis and Neisseria gonorrhoeae infections (CFDA 93.855, through May 2031); a $544,250 National Cancer Institute award investigating immune drivers of persistent oncogenic HPV infections in people living with HIV (CFDA 93.395, through July 2030); a $422,125 National Institute on Drug Abuse award on oral nicotine pouch use epidemiology among adolescents (CFDA 93.279, through June 2028); a $7.73 million cooperative agreement from the Office of the Assistant Secretary for Preparedness and Response to operate the National Emerging Special Pathogens Training and Education Center (NETEC, CFDA 93.825, through September 2030); and a $1.99 million Health Resources and Services Administration award supporting the Rural Nebraska Nursing Fellows program in undergraduate nursing education (CFDA 93.359, through September 2029). UNMC also received a $3.24 million National Institute on Aging award investigating interpersonal connectedness between persons with dementia and spousal caregivers (CFDA 93.866, through September 2029) and a $1.0 million National Science Foundation award developing artificial intelligence and machine learning frameworks for breast cancer detection and diagnosis (CFDA 47.070, through July 2029).

Recent federal contract activity shows 181 awards reaching completion in the next 24 months with combined potential value of $9.6 million, representing recompete exposure. Service Contract Inventory data for federal service contracts above the $150,000 threshold shows $3.4 million in SCI-reportable invoiced revenue from FY2022 to FY2024, with $2.5 million invoiced in FY2023 (10.4 FTEs) and $875 thousand in FY2024 (2.9 FTEs). Government-paid hourly rates on prime service contracts ranged from $21.90/hr at the 10th percentile to $548.44/hr at the 90th percentile, with a median of $94.37/hr. UNMC subcontracts to other prime contractors including National Strategic Research Institute for next-generation sequencing research support and medical countermeasure drug discovery, and Hennepin Healthcare Research Institute for support of the Scientific Registry of Transplant Recipients (SRTR) operated under HRSA contract.

UNMC also operates as a sub-recipient on federal grants, receiving awards from entities including Colorado State University (West Nile Virus research under NIAID CFDA 93.855), Nebraska Department of Health and Human Services (multiple public health preparedness, disease surveillance, and nursing workforce initiatives), and multi-institutional research consortia (e.g., Wichita State University for follicle-stimulating hormone signaling research, Johns Hopkins University for pediatric early mobility interventions, and Benaroya Research Institute for immune tolerance network clinical trials). The institution participates in federal grant sub-awards across infectious disease, cancer research, rural health workforce development, and emergency preparedness domains, with 399 sub-awards comprising 24 percent of the total award portfolio.